vs
ANAPTYSBIO, INC（ANAB）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是ANAPTYSBIO, INC的1.9倍（$200.5M vs $108.2M），ANAPTYSBIO, INC净利率更高（45.8% vs 2.2%，领先43.6%），ANAPTYSBIO, INC同比增速更快（151.1% vs 5.2%），ANAPTYSBIO, INC自由现金流更多（$98.0M vs $1.1M），过去两年ANAPTYSBIO, INC的营收复合增速更高（288.3% vs -3.3%）
AnaptysBio是一家处于临床阶段的生物技术企业，专注于开发适用于炎症疾病、肿瘤免疫及罕见病领域的抗体类免疫疗法，主要面向美国市场，推进创新候选药物管线研发以满足未被满足的临床需求。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
ANAB vs ROG — 直观对比
营收规模更大
ROG
是对方的1.9倍
$108.2M
营收增速更快
ANAB
高出145.8%
5.2%
净利率更高
ANAB
高出43.6%
2.2%
自由现金流更多
ANAB
多$96.9M
$1.1M
两年增速更快
ANAB
近两年复合增速
-3.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $108.2M | $200.5M |
| 净利润 | $49.6M | $4.5M |
| 毛利率 | — | 32.2% |
| 营业利润率 | 61.8% | — |
| 净利率 | 45.8% | 2.2% |
| 营收同比 | 151.1% | 5.2% |
| 净利润同比 | 327.8% | 421.4% |
| 每股收益（稀释后） | $1.64 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ANABROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $108.2M | $201.5M | ||
| Q3 25 | $76.3M | $216.0M | ||
| Q2 25 | $22.3M | $202.8M | ||
| Q1 25 | $27.8M | $190.5M | ||
| Q4 24 | $43.1M | $192.2M | ||
| Q3 24 | $30.0M | $210.3M | ||
| Q2 24 | $11.0M | $214.2M |
净利润ANABROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $49.6M | $4.6M | ||
| Q3 25 | $15.1M | $8.6M | ||
| Q2 25 | $-38.6M | $-73.6M | ||
| Q1 25 | $-39.3M | $-1.4M | ||
| Q4 24 | $-21.8M | $-500.0K | ||
| Q3 24 | $-32.9M | $10.7M | ||
| Q2 24 | $-46.7M | $8.1M |
毛利率ANABROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 31.6% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
营业利润率ANABROG
| Q1 26 | — | — | ||
| Q4 25 | 61.8% | 3.5% | ||
| Q3 25 | 45.5% | 7.3% | ||
| Q2 25 | -117.5% | -33.3% | ||
| Q1 25 | -99.2% | -0.2% | ||
| Q4 24 | -22.4% | -6.6% | ||
| Q3 24 | -75.8% | 6.9% | ||
| Q2 24 | -367.5% | 5.3% |
净利率ANABROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | 45.8% | 2.3% | ||
| Q3 25 | 19.8% | 4.0% | ||
| Q2 25 | -173.5% | -36.3% | ||
| Q1 25 | -141.6% | -0.7% | ||
| Q4 24 | -50.5% | -0.3% | ||
| Q3 24 | -109.4% | 5.1% | ||
| Q2 24 | -425.3% | 3.8% |
每股收益（稀释后）ANABROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $1.64 | $0.20 | ||
| Q3 25 | $0.52 | $0.48 | ||
| Q2 25 | $-1.34 | $-4.00 | ||
| Q1 25 | $-1.28 | $-0.08 | ||
| Q4 24 | $-0.63 | $-0.04 | ||
| Q3 24 | $-1.14 | $0.58 | ||
| Q2 24 | $-1.71 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $238.2M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $37.2M | $1.2B |
| 总资产 | $364.4M | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ANABROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $238.2M | $197.0M | ||
| Q3 25 | $109.8M | $167.8M | ||
| Q2 25 | $44.3M | $157.2M | ||
| Q1 25 | $98.6M | $175.6M | ||
| Q4 24 | $123.1M | $159.8M | ||
| Q3 24 | $191.6M | $146.4M | ||
| Q2 24 | $71.8M | $119.9M |
股东权益ANABROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $37.2M | $1.2B | ||
| Q3 25 | $-29.4M | $1.2B | ||
| Q2 25 | $-44.7M | $1.2B | ||
| Q1 25 | $34.0M | $1.3B | ||
| Q4 24 | $70.9M | $1.3B | ||
| Q3 24 | $84.4M | $1.3B | ||
| Q2 24 | $9.9M | $1.3B |
总资产ANABROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $364.4M | $1.4B | ||
| Q3 25 | $353.1M | $1.4B | ||
| Q2 25 | $335.3M | $1.5B | ||
| Q1 25 | $422.1M | $1.5B | ||
| Q4 24 | $483.8M | $1.5B | ||
| Q3 24 | $493.4M | $1.5B | ||
| Q2 24 | $427.4M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $98.0M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $98.0M | $1.1M |
| 自由现金流率自由现金流/营收 | 90.5% | 0.5% |
| 资本支出强度资本支出/营收 | 0.0% | 2.3% |
| 现金转化率经营现金流/净利润 | 1.98× | 1.29× |
| 过去12个月自由现金流最近4个季度 | $19.6M | $70.1M |
8季度趋势，按日历期对齐
经营现金流ANABROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $98.0M | $46.9M | ||
| Q3 25 | $-27.4M | $28.9M | ||
| Q2 25 | $-40.2M | $13.7M | ||
| Q1 25 | $-10.7M | $11.7M | ||
| Q4 24 | $-66.7M | $33.7M | ||
| Q3 24 | $-10.1M | $42.4M | ||
| Q2 24 | $-21.3M | $22.9M |
自由现金流ANABROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $98.0M | $42.2M | ||
| Q3 25 | $-27.4M | $21.2M | ||
| Q2 25 | $-40.3M | $5.6M | ||
| Q1 25 | $-10.7M | $2.1M | ||
| Q4 24 | $-66.9M | $18.3M | ||
| Q3 24 | $-10.1M | $25.2M | ||
| Q2 24 | $-21.4M | $8.8M |
自由现金流率ANABROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 90.5% | 20.9% | ||
| Q3 25 | -35.9% | 9.8% | ||
| Q2 25 | -180.9% | 2.8% | ||
| Q1 25 | -38.7% | 1.1% | ||
| Q4 24 | -155.3% | 9.5% | ||
| Q3 24 | -33.7% | 12.0% | ||
| Q2 24 | -194.6% | 4.1% |
资本支出强度ANABROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.0% | 2.3% | ||
| Q3 25 | 0.0% | 3.6% | ||
| Q2 25 | 0.2% | 4.0% | ||
| Q1 25 | 0.1% | 5.0% | ||
| Q4 24 | 0.6% | 8.0% | ||
| Q3 24 | 0.1% | 8.2% | ||
| Q2 24 | 0.3% | 6.6% |
现金转化率ANABROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | 1.98× | 10.20× | ||
| Q3 25 | -1.81× | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
